Patients on ACE inhibitors, ARBs, don't have higher COVID-19 risk, fFnds study
E-Mail NEW YORK, NY (Dec. 17, 2020)--While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives--and whether they posed increased risks to patients with hypertension. A new study by global collaborators within the Observational Health Data Sciences and Informatics (OHDSI) community found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angioten...
Source: eurekalert.org